Interdisciplinary Research to Understand the Vascular Contributions to Alzheimer's Disease (R01)
The summary for the Interdisciplinary Research to Understand the Vascular Contributions to Alzheimer's Disease (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Interdisciplinary Research to Understand the Vascular Contributions to Alzheimer's Disease (R01): The goal of this funding opportunity announcement is to support interdisciplinary research that will lead to a greater understanding of the mechanisms by which vascular factors contribute to the complex etiology of Alzheimer's disease.
Federal Grant Title: | Interdisciplinary Research to Understand the Vascular Contributions to Alzheimer's Disease (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AG-15-010 |
Type of Funding: | Grant |
CFDA Numbers: | 93.853, 93.866 |
CFDA Descriptions: | Extramural Research Programs in the Neurosciences and Neurological Disorders; Aging Research |
Current Application Deadline: | Feb 3, 2015 |
Original Application Deadline: | Feb 3, 2015 |
Posted Date: | August 25th, 2014 |
Creation Date: | Aug 25, 2014 |
Archive Date: | Mar 6, 2015 |
Total Program Funding: | $4,000,000 |
Maximum Federal Grant Award: | $750,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
County governments
City or township governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Special district governments - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-15-010.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Ge...
- • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
- • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...
- • Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contribution...
- • Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging fin...
- • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
- • NINDS Institutional Center Core Grants to Support Neuroscience Research
- • Career Development Award to Promote Diversity in Neuroscience Research
- More Grants from the National Institutes of Health
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
- • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...
- • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...